177 related articles for article (PubMed ID: 32187889)
1. GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRAS
Bera AK; Lu J; Lu C; Li L; Gondi S; Yan W; Nelson A; Zhang G; Westover KD
Birth Defects Res; 2020 Jun; 112(10):708-717. PubMed ID: 32187889
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the atypical activation mechanism of KRAS
Bera AK; Lu J; Wales TE; Gondi S; Gurbani D; Nelson A; Engen JR; Westover KD
J Biol Chem; 2019 Sep; 294(38):13964-13972. PubMed ID: 31341022
[TBL] [Abstract][Full Text] [Related]
3. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
Gremer L; Merbitz-Zahradnik T; Dvorsky R; Cirstea IC; Kratz CP; Zenker M; Wittinghofer A; Ahmadian MR
Hum Mutat; 2011 Jan; 32(1):33-43. PubMed ID: 20949621
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and functional characterization of germ line KRAS mutations.
Schubbert S; Bollag G; Lyubynska N; Nguyen H; Kratz CP; Zenker M; Niemeyer CM; Molven A; Shannon K
Mol Cell Biol; 2007 Nov; 27(22):7765-70. PubMed ID: 17875937
[TBL] [Abstract][Full Text] [Related]
5. Germline KRAS mutations cause Noonan syndrome.
Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
[TBL] [Abstract][Full Text] [Related]
6. An unexpected new role of mutant Ras: perturbation of human embryonic development.
Kratz CP; Niemeyer CM; Zenker M
J Mol Med (Berl); 2007 Mar; 85(3):227-35. PubMed ID: 17211612
[TBL] [Abstract][Full Text] [Related]
7. GTP hydrolysis mechanisms in ras p21 and in the ras-GAP complex studied by fluorescence measurements on tryptophan mutants.
Antonny B; Chardin P; Roux M; Chabre M
Biochemistry; 1991 Aug; 30(34):8287-95. PubMed ID: 1883817
[TBL] [Abstract][Full Text] [Related]
8. Allosteric site variants affect GTP hydrolysis on Ras.
Johnson CW; Fetics SK; Davis KP; Rodrigues JA; Mattos C
Protein Sci; 2023 Oct; 32(10):e4767. PubMed ID: 37615343
[TBL] [Abstract][Full Text] [Related]
9. KRAS Switch Mutants D33E and A59G Crystallize in the State 1 Conformation.
Lu J; Bera AK; Gondi S; Westover KD
Biochemistry; 2018 Jan; 57(3):324-333. PubMed ID: 29235861
[TBL] [Abstract][Full Text] [Related]
10. Measurement of KRAS-GTPase Activity.
Rabara D; Stephen AG
Methods Mol Biol; 2024; 2797():91-102. PubMed ID: 38570454
[TBL] [Abstract][Full Text] [Related]
11. Real-time in vitro measurement of intrinsic and Ras GAP-mediated GTP hydrolysis.
Shutes A; Der CJ
Methods Enzymol; 2006; 407():9-22. PubMed ID: 16757310
[TBL] [Abstract][Full Text] [Related]
12. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders.
Kratz CP; Schubbert S; Bollag G; Niemeyer CM; Shannon KM; Zenker M
Cell Cycle; 2006 Aug; 5(15):1607-11. PubMed ID: 16921267
[TBL] [Abstract][Full Text] [Related]
14. A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation.
Yin G; Kistler S; George SD; Kuhlmann N; Garvey L; Huynh M; Bagni RK; Lammers M; Der CJ; Campbell SL
J Biol Chem; 2017 Mar; 292(11):4446-4456. PubMed ID: 28154176
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
Tong LA; de Vos AM; Milburn MV; Kim SH
J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
[TBL] [Abstract][Full Text] [Related]
16. Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1).
Fang Z; Marshall CB; Yin JC; Mazhab-Jafari MT; Gasmi-Seabrook GM; Smith MJ; Nishikawa T; Xu Y; Neel BG; Ikura M
J Biol Chem; 2016 Jul; 291(30):15641-52. PubMed ID: 27226556
[TBL] [Abstract][Full Text] [Related]
17. KRAS gene mutations in Noonan syndrome familial cases cluster in the vicinity of the switch II region of the G-domain: report of another family with metopic craniosynostosis.
Brasil AS; Malaquias AC; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
Am J Med Genet A; 2012 May; 158A(5):1178-84. PubMed ID: 22488932
[TBL] [Abstract][Full Text] [Related]
18. The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS.
Li C; Vides A; Kim D; Xue JY; Zhao Y; Lito P
Science; 2021 Oct; 374(6564):197-201. PubMed ID: 34618566
[TBL] [Abstract][Full Text] [Related]
19. Transition state structures and the roles of catalytic residues in GAP-facilitated GTPase of Ras as elucidated by (18)O kinetic isotope effects.
Du X; Sprang SR
Biochemistry; 2009 Jun; 48(21):4538-47. PubMed ID: 19610677
[TBL] [Abstract][Full Text] [Related]
20. Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts.
Dunnett-Kane V; Burkitt-Wright E; Blackhall FH; Malliri A; Evans DG; Lindsay CR
Ann Oncol; 2020 Jul; 31(7):873-883. PubMed ID: 32240795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
